Abstract
Genetic and environmental factors are thought to play roles in the etiopathology of fibromyalgia syndrome (FMS). The objective of this study was to determine the potential effects of single nucleotide polymorphisms (SNPs) in catechol-O-methyltransferase (COMT) (rs4680) and 5-hydroxytryptamine (serotonin) 2A (5-HT2A) receptor (rs6313 and rs6311) genes on susceptibility to FMS. One hundred seventy-one women (80 FMS, 91 control) were enrolled in the study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for the genotyping analyses. Genotype and allele frequencies were calculated by the chi-square test. Beck depression inventory, state and trait anxiety inventory and symptom checklist-90 revised (SCL-90-R) tests were applied to both patients and controls. There were no observed differences in the frequencies of alleles and genotypes between patients and controls for the COMT, and the two 5-HT2A receptor gene polymorphisms (P > 0.05). Our results suggest that the investigated polymorphisms seem not to be the susceptibility factors in etiology of FMS.
Similar content being viewed by others
References
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28
Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, Kuck J, Leslie V, Masur D, Wagner M, Waid R, Zisook S (1999) Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40:57–63
Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67(8):1219–1225
Buskila D, Sarzi-Puttini P (2006) Biology and therapy of fibromyalgia.Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther 8(5):218
Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr (2004) Family study of fibromyalgia. Arthritis Rheum 50:944–952
Buskila D, Neumann L, Hazanov I, Carmi R (1996) Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 26:605–611
Gürsoy S, Erdal E, Herken H, Madenci E, Alasehirli B (2001) Association of T102C polymorphism of the 5HT2A receptor gene with pyschiatric status in fibromyalgia syndrome. Rheumatol Int 21(2):58–61
Gürsoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N (2003) Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23(3):104–107
Buskila D, Cohen H, Neumann L, Ebstein RP (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9(8):730–731
Su SY, Chen JJ, Lai CC, Chen CM, Tsai FJ (2007) The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin Rheumatol 26(1):12–16
Graeff FG (1997) Serotoninergic systems. Psychiatr Clin North Am 20:723–739
Tokunaga A, Saika M, Senba E (1998) 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain 76:349–355
Fuentes JA, Lauzurica N, Hurtado A, Escartí A, Barrios V, Morande G, Soriano J, Jauregui I, Gonzalez-Valdemoro MI, Garcia-Camba E (2004) Analysis of the −1438 G/A polymorphism of the 5-HT2A serotonin receptor gene in bulimia nervosa patients with or without a history of anorexia nervosa. Psychiatr Genet 14(2):107–109
Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW. (1998) Evidence for association between polymorphism in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry 3:61–66
Williams J, Spurlock G, McGuffin P, Mallet J, Nöthen MM, Gill M, Aschauer H, Nylander PO, Macciardi F, Owen MJ (1996) Association between schizophrenia and T102C polymorphism of the 5-hydroxytrytamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 347:1294–1296
Seretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E (1999) Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry 4:280–283
Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, de Jonge S, Krüger M, Engel RR, Färber L, Pongratz DE, Ackenheil M (1999) The T102C polymorphism of the 5-HT2A-receptor gen in fibromyalgia. Neurobiol Dis 6:433–439
Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Krüger M, Schoeps P, Ackenheil M (1999) Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42(11):2482–488
Enoch MA, Goldman D, Barnett R, Sher L, Mazzanti CM, Rosenthal NE (1999) Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, −1438G/A. Mol Psychiatry 4:89–92
Tot S, Erdal E, Yazici K, Yazici AE, Metin O (2003) T102C and −1438 G/A polymorphisms of the receptor gene in Turkish patients with obsessive-compulsive disorder. Eur Psychiatry 18:249–254
Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6(3):243–250
Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, Derici E, Camdeviren H (2003) Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety 18(1):41–45
Sazci A, Ergul E, Kucukali I, Kilic G, Kaya G, Kara I (2004) Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Brain Res Mol Brain Res 132(1):51–56
Hudson JI, Arnold LM, Keck PE, Auchenbach MB, Pope HG (2004) Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 56:884–891
Ackenheil M (1998) Genetics and pathopsiology of affective disorders: relationship to fibromyalgia. Z Rheumatol 57(2):5–7
Buskila D (2007) Genetics of chronic pain states. Best Pract Res Clin Rheumatol 21(3):535–547
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. The American Psychiatric Association, Washington, DC
Derogatis LR (1977) SCL-90-R administration scoring and procedures manual-I for the revised version. Johns Hopkins University School of Medicine, Baltimore
Dağ İ (1991) Belirti Tarama Listesi SCL-90-R’nin üniversite öğrencileri için güvenirliği geçerliği. Türk Psikiyatri Dergisi 2:5–12
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Hisli N (1988) The reliability and validity study of the Beck Depression Inventory in a Turkish sample. Psikoloji Dergisi 6:118–122 (in Turkish)
Spielberger CD, Gorsuch RL, Lusahene RE (1970) Manual for stait-trait anxiety inventory. California Consulting Psychologist Press, Palo Alto
Ozer AK (1994) Sürekli Öfke ve öfke ifade tarzı ölçekleri ön çalışması. Türk Psikoloji Dergisi 31:26–35
Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18(5):728–733
Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire. Rheumatol Int 20(1):9–12
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
National Center for Biotechnology Information LocusLink Database. http://www.ncbi.nih.gov/LocusLink
Cohen H, Buskila D, Neumann L, Ebstein RP (2002) Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and the relationship to anxiety related personality traits. Arthritis Rheum 46(3):845–847
Frank B, Niesler B, Bondy B, Späth M, Pongratz DE, Ackenheil M, Fischer C, Rappold G (2004) Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin Rheumatol 23:338–344
Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243
Gürsoy S (2002) Absence of association of the serotonin transporter gene polymorphism with mentally healthy subset of fibromyalgia patients. Clin Rheumatol 21:194–197
Acknowledgments
This study was supported by the Ondokuzmayis University Research Foundation (No. T-368).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tander, B., Gunes, S., Boke, O. et al. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int 28, 685–691 (2008). https://doi.org/10.1007/s00296-008-0525-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-008-0525-8